Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
None USD 0.00(0%)
Last update at 2025-10-02T20:12:21.855657Z
Market Cap
3.08M

Momentum Score

…

CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, that includes oils, waxes, edibles, and shatters; and provides toll processing services. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators. It offers its products under Oasis Cannabis and City Trees brand names. The company's concentrates are used for pharmaceutical and other purposes. CLS Holdings USA, Inc. was founded in 2014 and is based in Las Vegas, Nevada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.03
Low
0.12
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
22.20M
Revenue Per Share
0.31
Gross Profit TTM
10.57M
Debt / Equity
-
ROE
-631.73%
Net Debt
10.55M
ROCE
20.02%
Diluted EPS TTM
-0.20

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Income before tax -12.62M -0.40M -13.40M -30.66M -27.62M
Minority interest 1.04M 0.10M - - -
Net income -13.80M -2.34M -15.89M -30.66M -27.62M
Selling general administrative 11.11M 12.42M 10.80M 8.78M 26.47M
Gross profit 9.80M 11.54M 9.65M 5.96M 3.62M
Reconciled depreciation 0.95M 0.75M 0.69M 1.75M 0.29M
Ebit -1.26M -0.88M -1.15M -2.82M -6.94M
Ebitda -9.00M 2.50M -9.06M -25.97M -22.88M
Operating income -1.30M -0.88M -1.15M -2.82M -22.85M
Other operating expenses 0.92M 0.81M 0.81M 0.81M 0.20M
Interest expense 2.67M 2.15M 3.66M 2.94M 4.45M
Tax provision 2.22M 2.04M 2.49M 0.00M 0.00M
Net interest income -2.67M -2.15M -3.66M -2.94M -4.45M
Income tax expense 2.22M 2.04M 2.49M - -
Total revenue 23.13M 22.66M 19.29M 11.92M 8.46M
Total operating expenses 24.44M 23.54M 20.45M 14.74M 31.31M
Cost of revenue 13.33M 11.12M 9.64M 5.96M 4.84M
Total other income expense net -8.65M 2.63M -8.59M -24.90M -0.32M
Net income from continuing ops -14.84M -2.44M -15.89M -30.66M -27.62M
Net income applicable to common shares -13.80M -2.34M -15.89M -30.66M -27.62M
Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Total assets 10.07M 15.83M 11.60M 15.27M 46.50M
Intangible assets 0.21M 1.19M 1.31M 1.42M 1.53M
Other current assets - 0.00M 0.00M 0.00M 0.21M
Total liab 23.87M 32.98M 26.69M 20.66M 21.47M
Total stockholder equity -12.66M -17.05M -15.10M -5.40M 25.04M
Other current liab 6.75M 4.53M 2.49M 0.15M 1.15M
Common stock 0.01M 0.00M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings -108.88M -95.08M -92.74M -76.85M -46.19M
Good will 0.56M 0.56M 0.56M 0.56M 25.74M
Other assets 0.16M 0.23M 0.17M 0.17M 4.64M
Cash 1.00M 2.55M 1.67M 2.93M 10.53M
Total current liabilities 16.34M 28.11M 4.98M 1.88M 6.92M
Net debt 10.55M 20.60M 18.40M 14.72M 7.95M
Short term debt - - - - 3.93M
Short long term debt 5.76M 20.46M 0.33M - 3.93M
Other stockholder equity 0.07M 0.07M 0.07M 0.24M 0.46M
Property plant equipment 4.55M 6.50M 5.73M 5.18M 1.91M
Total current assets 4.59M 6.88M 3.84M 7.94M 12.68M
Long term investments 0.00M 0.47M - 0.00M 0.00M
Net tangible assets -13.43M -18.80M -16.96M -7.37M -2.23M
Short term investments - - - - 0.21M
Net receivables 0.43M 0.62M 0.69M 4.21M 1.01M
Long term debt 5.79M 2.69M 19.73M 17.64M 14.54M
Inventory 3.01M 3.42M 1.23M 0.58M 0.75M
Accounts payable 1.79M 1.41M 0.77M 0.59M 0.51M
Non currrent assets other - - - 0.17M 0.17M
Non current assets total 5.48M 8.94M 7.76M 7.33M 33.83M
Capital lease obligations 2.21M 2.55M 2.27M 1.47M -
Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Investments -0.30M -0.58M -0.58M -0.58M -12.17M
Change to liabilities 2.87M 2.75M 2.93M -0.07M -0.48M
Total cashflows from investing activities -0.11M 0.99M 1.27M -0.44M -12.17M
Net borrowings -1.22M 3.05M 3.05M -4.00M 17.27M
Total cash from financing activities -1.22M 3.05M 3.05M -4.00M 32.81M
Change to operating activities 0.74M 0.12M 0.04M 0.20M 0.39M
Net income -13.80M -2.34M -15.89M -30.66M -27.62M
Change in cash -1.55M 0.89M -1.26M -7.60M 10.47M
Begin period cash flow 2.55M 1.67M 2.93M 10.53M 0.05M
End period cash flow 1.00M 2.55M 1.67M 2.93M 10.53M
Total cash from operating activities -0.23M -3.16M -2.54M -3.16M -10.16M
Issuance of capital stock - - - 0.00M 15.54M
Depreciation 0.95M 0.75M 0.69M 0.45M 0.29M
Other cashflows from investing activities 0.35M 2.74M 1.54M 1.68M 1.68M
Change to inventory 0.40M -2.19M -0.65M 0.17M -0.34M
Change to account receivables 0.14M 0.06M -0.54M -0.11M -0.13M
Change to netincome 7.65M -2.64M 8.69M 25.21M 14.16M
Capital expenditures 0.15M 1.17M 0.27M 1.92M 1.04M
Change in working capital 4.16M 0.74M 1.78M -1.11M -0.57M
Stock based compensation - - - - 0.00M
Other non cash items 0.16M -2.40M 2.27M 1.54M 17.72M
Free cash flow -0.38M -4.26M -2.80M -5.11M -11.20M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MKKGY
Merck KGaA ADR
-0.68
2.09%
31.83 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
163.45 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.38
1.77%
21.79 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.05 - 10.66 0.01 1.16 2.94 23.11

Profile*

CLS Holdings USA Inc

CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, that includes oils, waxes, edibles, and shatters; and provides toll processing services. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators. It offers its products under Oasis Cannabis and City Trees brand names. The company's concentrates are used for pharmaceutical and other purposes. CLS Holdings USA, Inc. was founded in 2014 and is based in Las Vegas, Nevada.

11767 South Dixie Highway, Miami, FL, United States, 33156

888 438 9132

Name Title Year Born
Mr. Andrew J. Glashow CEO, Pres, Principal Financial & Accounting Officer, Sec. and Director 1963
Ms. Charlene Soco Exec. VP of Fin. 1991

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…